ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI

ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI was reported 77 times

ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT 6 0.5455
1 COAGULATION FACTOR VIII LEVEL DECREASED 12 0.0732
2 GASTROSTOMY FAILURE 1 0.0323
3 INHIBITING ANTIBODIES 1 0.0143
4 ALLERGIC TRANSFUSION REACTION 1 0.0066
5 ANTI FACTOR VIII ANTIBODY POSITIVE 3 0.0053
6 TONGUE HAEMATOMA 1 0.0051
7 HISTAMINE INTOLERANCE 1 0.0044
8 HAEMOPHILIC ARTHROPATHY 1 0.0042
9 POST PROCEDURAL CONTUSION 1 0.0030
10 PERIPROSTHETIC FRACTURE 1 0.0026
11 HAEMATOMA MUSCLE 3 0.0025
12 HAEMOBILIA 1 0.0024
13 APPARENT LIFE THREATENING EVENT 1 0.0024
14 SPLENIC HAEMORRHAGE 1 0.0020
15 DRUG LEVEL ABNORMAL 1 0.0019
16 LIP DISCOLOURATION 1 0.0008
17 SUBCUTANEOUS HAEMATOMA 1 0.0008
18 PHARYNGEAL PARAESTHESIA 1 0.0006
19 PANCREATIC FAILURE 1 0.0006
20 HAEMARTHROSIS 5 0.0006
21 COMPARTMENT SYNDROME 1 0.0004
22 ABDOMINAL MASS 1 0.0004
23 ENDOTRACHEAL INTUBATION 1 0.0004
24 LUMBAR SPINAL STENOSIS 1 0.0003
25 PROSTATITIS 1 0.0003
26 FACET JOINT SYNDROME 1 0.0003
27 PEPTIC ULCER 1 0.0003
28 HAEMORRHAGIC DIATHESIS 1 0.0003
29 APPENDICECTOMY 1 0.0003
30 CHRONIC SINUSITIS 1 0.0003
31 PROCEDURAL HAEMORRHAGE 1 0.0003
32 MUSCLE HAEMORRHAGE 1 0.0002
33 GALLBLADDER OPERATION 1 0.0002
34 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
35 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
36 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
37 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
38 HAEMORRHAGE 17 0.0002
39 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
40 RESPIRATION ABNORMAL 1 0.0001
41 MAJOR DEPRESSION 1 0.0001
42 MOUTH HAEMORRHAGE 1 0.0001
43 RESPIRATORY DISTRESS 3 0.0001
44 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
45 HYPERTENSIVE CRISIS 1 0.0001
46 SPINAL PAIN 1 0.0001
47 TOOTH EXTRACTION 1 0.0001
48 HAEMATOMA 2 0.0001
49 HIP ARTHROPLASTY 1 0.0001
50 PHARYNGEAL OEDEMA 1 0.0001
51 PNEUMOTHORAX 1 0.0001
52 FACE OEDEMA 1 0.0001
53 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
54 CEREBRAL HAEMORRHAGE 2 0.0001
55 GASTRIC ULCER 1 0.0001
56 PRESYNCOPE 1 0.0000
57 CARDIOVASCULAR DISORDER 1 0.0000
58 RESPIRATORY TRACT INFECTION 1 0.0000
59 THROAT TIGHTNESS 1 0.0000
60 PALLOR 1 0.0000
61 THERAPEUTIC RESPONSE DECREASED 2 0.0000
62 HEAD INJURY 1 0.0000
63 CYSTITIS 1 0.0000
64 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
65 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
66 JOINT SWELLING 3 0.0000
67 ANGIOEDEMA 1 0.0000
68 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
69 THROAT IRRITATION 1 0.0000
70 THERAPY NON-RESPONDER 1 0.0000
71 BLOOD CHOLESTEROL INCREASED 1 0.0000
72 AGGRESSION 1 0.0000
73 FLUSHING 2 0.0000
74 ERYTHEMA 4 0.0000
75 OEDEMA 1 0.0000
76 ANAPHYLACTIC REACTION 1 0.0000
77 DYSPHONIA 1 0.0000
78 WHEEZING 1 0.0000
79 ILL-DEFINED DISORDER 1 0.0000
80 FEELING HOT 1 0.0000
81 INJURY 1 0.0000
82 HOSPITALISATION 2 0.0000
83 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
84 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
85 CHEST PAIN 2 0.0000
86 HYPERSENSITIVITY 2 0.0000
87 SWELLING 1 0.0000
88 DRUG INTOLERANCE 1 0.0000
89 CHEST DISCOMFORT 1 0.0000
90 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
91 ARTHRALGIA 4 0.0000
92 INFLUENZA 1 0.0000
93 BACK PAIN 2 0.0000
94 ASTHENIA 3 0.0000
95 HYPERHIDROSIS 1 0.0000
96 PRODUCT QUALITY ISSUE 1 0.0000
97 COUGH 2 0.0000
98 DRUG INEFFECTIVE 9 0.0000
99 PRODUCT DOSE OMISSION ISSUE 2 0.0000
100 CONDITION AGGRAVATED 2 0.0000
101 PERIPHERAL SWELLING 1 0.0000
102 DIZZINESS 3 0.0000
103 FALL 2 0.0000
104 MYOCARDIAL INFARCTION 1 0.0000
105 DYSPNOEA 3 0.0000
106 GAIT DISTURBANCE 1 0.0000
107 ABDOMINAL PAIN 1 0.0000
108 PAIN 2 0.0000
109 HEADACHE 2 0.0000
110 DEATH 2 0.0000
111 MALAISE 1 0.0000
112 NAUSEA 1 0.0000
113 OFF LABEL USE 1 0.0000